Research Article
Perioperative Exhaled Nitric Oxide as an Indicator for Postoperative Pneumonia in Surgical Lung Cancer Patients: A Prospective Cohort Study Based on 183 Cases
Table 1
Baseline and clinical characteristics of the two groups.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
#Data with mean ± SD, ##data with median (interquartile range), and data with significant differences. POP: postoperative pneumonia; BMI: body mass index; current smoking: still smoking in last 3 months; ex-smokers: quit smoking for more than 1 year; COPD: chronic obstructive pulmonary disease; CVD: cardiovascular disease including hypertension and coronary heart disease; DM: diabetes mellitus; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; DLCO: diffusion capacity of the lung for carbon monoxide; FeNO: fractional exhaled nitric oxide; WBC: white blood cell; N: neutrophil granulocyte; EO: eosinophil granulocyte, POD: postoperative day; RUL: right upper lobe; RML: right middle lobe; RLL: right lower lobe; LUL: left upper lobe; LLL: left lower lobe. |